Bristol Myers Squibb
5/10
Bristol Myers Squibb carries $44.8B in long-term debt, with $8.8B in scheduled principal maturities. Notably, the entire $8.8B maturity schedule falls within five years, creating a concentrated refinancing window. DebtCanary scores BMY at 5/10, indicating moderate refinancing pressure.
Maturity Schedule
| Period | Amount Due |
|---|---|
| Year 1 (0-12 months) | $2.0B |
| Year 2 (12-24 months) | $2.0B |
| Year 3 (24-36 months) | $544M |
| Year 4 (36-48 months) | $2.2B |
| Year 5 (48-60 months) | $2.1B |
| Beyond 5 Years | N/A |
| Total Scheduled Maturities | $8.8B |
Key Metrics
Score Components
| Component | Value |
|---|---|
| Near-Term Maturity Concentration | 22.6% |
| Interest Coverage Ratio | N/A |
| Debt-to-Equity Ratio | 2.43 |
| Cash Coverage of Near-Term Debt | 5.10x |
Recent SEC Filings
Material disclosures from Bristol Myers Squibb's most recent EDGAR filings. 8-K item labels indicate the type of event reported.
| Date | Form | Details |
|---|---|---|
| 2026-04-17 | DEFA14A | Additional proxy materials |
| 2026-03-25 | DEFA14A | Additional proxy materials |
| 2026-03-25 | DEF 14A | Proxy statement |
| 2026-02-11 | 10-K | Annual report |
| 2026-02-05 | 8-K | Earnings Results, Reg FD Disclosure |
| 2026-01-12 | 8-K | Reg FD Disclosure |
| 2025-11-18 | 8-K | Other Events |
| 2025-11-10 | 8-K | Other Events |
Related Companies
Data Source:
Financial data sourced from SEC EDGAR XBRL filings (10-K annual reports).
Fiscal period end: 2025-12-31.
Filing date: 2026-02-11.
Data last fetched: 2026-04-30.
Maturity schedules reflect the company's most recently reported debt repayment obligations.
Data quality: Partial.
View SEC EDGAR filings for Bristol Myers Squibb →